$CoreWeave, Inc.(CRWV)$ $Salesforce.com(CRM)$ $Snowflake(SNOW)$
Current market conditions have triggered an AI Software Stress Test, challenging the sustainability of traditional SaaS models and questioning the role of Claude as either a partner or a replacement
The capacity for AI stocks to assure a continued market rally depends on consistent EPS growth, regulatory adaptation, and proof of AI-driven cost savings amidst growing volatility
The new AI era hinges on whether CoreWeave (CRWV) can sustain infrastructure demand via its $8.5 billion raise, positioning itself as a key player in AI workloads, while Salesforce (CRM) and Snowflake (SNOW) strive to prove the "partner or replacement" thesis through Agentforce monetization and rebounding data consumption for RAG (Retrieval-Augmented Generation) systems
The stress test is revealing a gap between AI-literate companies and those merely bolting on features; the winners will be those using AI to reinvent their business models, while the losers will be those treating it as just a simple plugin。。。
AI Software Stress Test: Is Claude Their Partner or Replacement?
@Tiger_comments:In early February, U.S. tech stocks narrowly escaped a scare triggered by fears that "AI software might be replaced." Although the partnership between AMD and Meta restored some confidence yesterday, the market remains on edge. Over the past three months, software stocks have endured a "massacre." Investors previously assumed that AI Agents would act like bulldozers, leveling traditional software companies. However, a recent presentation by AI giant Anthropic shifted the narrative: Claude no longer aims to be the "Terminator"; it wants to be a "Partner." Market Status: From "Universal Hype" to "Selective Picking" Recent price action shows a shift in the market's attitude toward AI: Focus on Efficiency, Not Just Growth: Previously, simply mentioning "AI" sent stock prices up. Now, if your AI investment is high and revenue generation is slow, the market responds with an immediate sell-off. $CoreWeave, Inc.(CRWV)$: The market focuses on CoreWeave’s plan to raise $8.5 billion. Credit & Interest: With a B+ rating, can it leverage Meta’s credit backing to lower interest rates? If financing hits a snag (e.g., rumors of failed $4 billion talks with Blue Owl), its high leverage could become a market nightmare. Whether it can reach the 850MW computing power target by the end of 2026. $Salesforce.com(CRM)$: Is Anyone Actually Paying for AI? All eyes are on the $550 million ARR (Annual Recurring Revenue). This is the litmus test for "AI software monetization." If numbers miss, the market will fear AI is "cannibalizing" traditional subscriptions rather than driving growth. Whether FY2026 revenue guidance can maintain double-digit growth. If it drops to single digits, fears of a "SaaSpocalypse" (Software Apocalypse) will intensify. $Snowflake(SNOW)$: Is "Data Consumption" Rebounding? Previous slowdowns worried the market. Investors want to see growth above 25%–28%. Anything less suggests that after buying chips, companies aren't actually busy processing data. RPO expected between $8.8B – $9.0B. This reflects future spending intent and is key to determining if AI demand is "phantom heat" or real. Note: Former darling $C3.ai, Inc.(AI)$ also reports after the bell tonight. Can AI stocks assure the market rally? Who will prove themselves in the new AI era? Leave your comments to win tiger coins!
AI Software Stress Test: Is Claude Their Partner or Replacement?Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.